Dulaglutide (Trulicity)
No pricing data available yet for this peptide.
Pricing data is updated regularly.
Dulaglutide is a long-acting GLP-1 receptor agonist consisting of a GLP-1 analog covalently linked to a modified IgG4 Fc domain via a small peptide linker. This design extends its half-life to approximately 5 days, enabling once-weekly dosing. It activates GLP-1 receptors on pancreatic beta cells to stimulate glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and acts centrally on hypothalamic appetite centers to reduce food intake and promote satiety.
| Level | Amount | Frequency | Timing |
|---|---|---|---|
| Beginner | 0.75 mg | Once weekly | Any time of day, with or without meals |
| Standard | 1.5 mg | Once weekly | Same day each week, any time |
| Advanced | 3.0-4.5 mg | Once weekly | Higher doses for weight management goals |
Ongoing as prescribed; research protocols vary
Approximately 5 days
Pre-filled pen device, no reconstitution needed
Refrigerate at 36-46°F, protect from light
Pre-filled; can be stored at room temperature ≤86°F for up to 14 days
Explore peer-reviewed studies and clinical research on Dulaglutide
Peer-reviewed medical research
Active and completed clinical trials
Academic papers and citations
Evidence-based supplement analysis
Research Disclaimer: These links lead to external research databases. Always consult with a qualified healthcare provider before making decisions based on research literature.
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare professional before using any peptide. BioProtocol does not sell peptides or pharmaceutical products.